News About: Goverment
Increased coverage for low-income earners
The government will increase health insurance benefits for low-income brackets and those in unemployment or retirement, the Health Ministry announced on March 30.
Those who make less than 50 percent of the average ...
Lawmaker calls for tax waiver over rare disease treatments
A lawmaker has proposed a revised bill that that the government should implement steps to waiver import duties and value added taxes levied on a medicine that treats a rare disease, such as Elaprase (idursulfase), Nag...
KFDA to strengthen drug monitoring system
The Korea Food and Drug Administration held its information session over drug surveillance business guideline in a bid to help understand local drugmakers drug related safety guidelines in a detailed manner.
The se...
KFDA unveils drug re-evaluation results
The Korea Food and Drug Administration announced on March 26 that it will retract its approval for problematic 14 generic drugs in terms of bioequivalence, banning pharmaceutical companies from manufacturing and selli...
Civil groups to ask for cheaper access to Glivec
11 civic groups in Korea have called for the National Health Insurance Corporation to lower the current price for Glivec of Swiss maker by 37.5 percent, ahead of the negotiation deadline (April 6) between the NHIC and...
KFDA opens patent information Web site for 70 blockbuster medicines
The Korea Food and Drug Administration said on March 25 that it has introduced a drug patent information Web site (www.medipatent.kfda.go.kr) “Informetics” for domestic pharmaceutical firms to facilitate efforts of th...
Prices of 124 lipid-lowering agents to be reduced by 15%
The Ministry of Health, Welfare and Family Affairs released on March 23 the results of its economic feasibility assessment on cholesterol-lowering drugs, as part of the government's efforts to lower drug costs.
The...
CTD regulations will be obligatory to new drug application, KFDA says
The Korea Food and Drug Administration says the common technical document (CTD) related regulations will be compulsorily applicable to new drug application from this March, but its full implementation to other medicin...
Second test run prescription plan to be implemented
The second government-imposed review of prescribed drugs, the so-called Drug Utilization Review (DUR) system, is to be introduced in some pharmacies and hospitals of Koyang, Kyunggi Province, from April 15.
Under t...
Sebivo fails to get health insurance
Sebivo (telbivudine), a new antiviral drug used in the treatment of hepatitis infection, failed to receive health insurance benefit, according to Novartis Korea.
The Health Insurance Review and Assessment Service s...
